SHENMAO Launches New Thermal Fatigue Resistant Lead-free Solder Paste

SHENMAO America, Inc. is pleased to introduce its PF918-P250 Thermal Fatigue Resistance Lead-free Solder Paste. The new paste is formulated with the new SHENMAO Sn/4Ag/3Bi Alloy design with high thermal impact reliability.

Solder Paste PF918-P250. Image Credit: SHENMAO America, Inc.

PF918-P250 can increase thermal reliability performance by a minimum of 30 percent. It provides better mechanical shock performance than typical solder alloys such as SAC305 and SAC405, and is suitable for use in consumer electronics, servers and automotive electronics applications.

PF918-P250 has a similar melting point to SAC305 so that the regular SAC305 reflow profile can be applied.  With the innovative flux design, voiding can be easily controlled to less than 10 percent.

SHENMAO has successfully been approved by many international well-known electronic manufacturers. The company strives to offer the best quality without compromising cost and time-to-market while providing maximum value to all customers. SHENMAO America, Inc. blends SMT solder paste at its facility in San Jose, CA for distribution in North America.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Shenmao Technology Inc. (2021, June 08). SHENMAO Launches New Thermal Fatigue Resistant Lead-free Solder Paste. AZoM. Retrieved on December 17, 2024 from https://www.azom.com/news.aspx?newsID=56253.

  • MLA

    Shenmao Technology Inc. "SHENMAO Launches New Thermal Fatigue Resistant Lead-free Solder Paste". AZoM. 17 December 2024. <https://www.azom.com/news.aspx?newsID=56253>.

  • Chicago

    Shenmao Technology Inc. "SHENMAO Launches New Thermal Fatigue Resistant Lead-free Solder Paste". AZoM. https://www.azom.com/news.aspx?newsID=56253. (accessed December 17, 2024).

  • Harvard

    Shenmao Technology Inc. 2021. SHENMAO Launches New Thermal Fatigue Resistant Lead-free Solder Paste. AZoM, viewed 17 December 2024, https://www.azom.com/news.aspx?newsID=56253.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.